BCM
CLBT icon

Brown Capital Management’s Cellebrite CLBT Stock Holding History

Brown Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Sell
1,140,261
-1,562,118
-58% -$20.6M 3.33% 10
2026
Q1 		$37.2M Buy
+2,702,379
New +$40.7M 5.29% 3

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Brown Capital Management's CLBT Position: Q2 2026 in Review

Brown Capital Management reduced its Cellebrite (CLBT) stake by 58% in Q2 2026, selling an estimated $20.6M and leaving 1,140,261 shares worth $16.6M. The position accounts for 3.33% of the portfolio, ranked #10.

Brown Capital Management first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. The position peaked at $37.2M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Brown Capital Management held 1,140,261 shares of Cellebrite worth $16.6M as of Q2 2026.
  • Brown Capital Management sold 1,562,118 Cellebrite shares in Q2 2026, an estimated $20.6M.
  • Cellebrite made up 3.33% of Brown Capital Management's portfolio in Q2 2026, its #10 holding.
  • Brown Capital Management first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • Brown Capital Management's Cellebrite position peaked at $37.2M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Brown Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.